Perioperative Hyperglycaemia in Primary Total Hip and Knee Replacement
NCT ID: NCT01021826
Last Updated: 2015-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
193 participants
OBSERVATIONAL
2009-12-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement
NCT01743313
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
NCT05666479
Predictors and Outcomes of Intraoperative Hypothermia in Patients Undergoing Knee Arthroplasty
NCT04575246
Early Perioperative Quality Of Recovery After Hip and Knee Arthroplasty: a Retrospective Comparative Cohort Study
NCT06107296
Identification of Risk Factors of Prolonged Wound Healing Following Primary Arthroplasty
NCT01477047
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hip and knee replacements recipients
Osteoarthritis patients undergoing elective primary hip and knee replacement and being followed-up in this study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for primary hip or knee replacement
Exclusion Criteria
* Medication affecting glucose metabolism (excl. antidiabetic agents)
* Not undergoing hip or knee replacement
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University
OTHER
Coxa, Hospital for Joint Replacement
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Esa Jamsen
MD, PhD, Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Teemu Moilanen, MD, PhD
Role: STUDY_DIRECTOR
Coxa, Hospital for Joint Replacement
Esa Jämsen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Coxa, Hospital for Joint Replacement
Pasi Nevalainen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coxa, Hospital for Joint Replacement
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jamsen E, Nevalainen PI, Eskelinen A, Kalliovalkama J, Moilanen T. Risk factors for perioperative hyperglycemia in primary hip and knee replacements. Acta Orthop. 2015 Apr;86(2):175-82. doi: 10.3109/17453674.2014.987064. Epub 2014 Nov 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HyTe-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.